Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Gilead Waives Acquisition Option As Pionyr Explores Other Strategies
$315m Buy Off The Cards
Mar 24 2023
•
By
Ayisha Sharma
Pionyr Can Now Consider Different Pathways For Its Future • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business